Konidaris Tasos
- SEC CIK
- 0001320982
No open-market purchases or sales filed in the past year.
Current role at each company
- AMRX Amneal Pharmaceuticals, Inc.Executive Vice President & CFOas of Mar 5, 2026
- KDMN Kadmon Holdings, Inc.Directoras of Nov 9, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Konidaris Tasos as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMRX Amneal Pharmaceuticals, Inc.
Executive Vice President & CFO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 (view filing) | Aug 13-15 | 2 days | Konidaris TasosExecutive Vice President & CFO | SSaleClass A Common Stock | −499.7K | $9.33 | −$4.66M | −80.4%122.2K after | 3 lots |
| Mar 7, 2025 (view filing) | Mar 5 | 2 days | Konidaris TasosExecutive Vice President & CFO | SSaleClass A Common Stock | −100.0K | $8.91 | −$891.0K | −13.9%621.9K after |